367 related articles for article (PubMed ID: 17519301)
1. Acetaminophen and ibuprofen for prevention of adverse reactions associated with childhood immunization.
Manley J; Taddio A
Ann Pharmacother; 2007 Jul; 41(7):1227-32. PubMed ID: 17519301
[TBL] [Abstract][Full Text] [Related]
2. Prophylaxis with acetaminophen or ibuprofen for prevention of local reactions to the fifth diphtheria-tetanus toxoids-acellular pertussis vaccination: a randomized, controlled trial.
Jackson LA; Dunstan M; Starkovich P; Dunn J; Yu O; Nelson JC; Rees T; Zavitkovsky A
Pediatrics; 2006 Mar; 117(3):620-5. PubMed ID: 16510639
[TBL] [Abstract][Full Text] [Related]
3. An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccine.
Langley JM; Predy G; Guasparini R; Law B; Diaz-Mitoma F; Whitstitt P; Tapiero B; Dionne M; Tomovici A; Mills E; Halperin SA
Vaccine; 2007 Jan; 25(6):1121-5. PubMed ID: 17045366
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous vaccination of Chinese applicants for a United States immigrant visa.
Hua L; Hongtao H; Shunqin W; Jinping G; Jiandong C; Zhaoliang L; Xinwen F
Travel Med Infect Dis; 2008 May; 6(3):130-6. PubMed ID: 18486068
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine.
Pichichero ME; Bernstein H; Blatter MM; Schuerman L; Cheuvart B; Holmes SJ;
J Pediatr; 2007 Jul; 151(1):43-9, 49.e1-2. PubMed ID: 17586189
[TBL] [Abstract][Full Text] [Related]
6. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
[TBL] [Abstract][Full Text] [Related]
7. Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age.
Black S; Friedland LR; Ensor K; Weston WM; Howe B; Klein NP
Pediatr Infect Dis J; 2008 Apr; 27(4):341-6. PubMed ID: 18316985
[TBL] [Abstract][Full Text] [Related]
8. Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.
Zepp F; Knuf M; Habermehl P; Mannhardt-Laakmann W; Howe B; Friedland LR
J Pediatr; 2006 Nov; 149(5):603-610. PubMed ID: 17095328
[TBL] [Abstract][Full Text] [Related]
9. Needle size for vaccination procedures in children and adolescents.
Beirne PV; Hennessy S; Cadogan SL; Shiely F; Fitzgerald T; MacLeod F
Cochrane Database Syst Rev; 2015 Jun; (6):CD010720. PubMed ID: 26086647
[TBL] [Abstract][Full Text] [Related]
10. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
[TBL] [Abstract][Full Text] [Related]
11. How soon after a prior tetanus-diphtheria vaccination can one give adult formulation tetanus-diphtheria-acellular pertussis vaccine?
Halperin SA; Sweet L; Baxendale D; Neatby A; Rykers P; Smith B; Zelman M; Maus D; Lavigne P; Decker MD
Pediatr Infect Dis J; 2006 Mar; 25(3):195-200. PubMed ID: 16511379
[TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity of a pentavalent vaccine compared with separate administration of licensed equivalent vaccines in US infants and toddlers and persistence of antibodies before a preschool booster dose: a randomized, clinical trial.
Guerra FA; Blatter MM; Greenberg DP; Pichichero M; Noriega FR;
Pediatrics; 2009 Jan; 123(1):301-12. PubMed ID: 19117896
[TBL] [Abstract][Full Text] [Related]
13. Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America.
Pickering LK; Baker CJ; Freed GL; Gall SA; Grogg SE; Poland GA; Rodewald LE; Schaffner W; Stinchfield P; Tan L; Zimmerman RK; Orenstein WA;
Clin Infect Dis; 2009 Sep; 49(6):817-40. PubMed ID: 19659433
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of ibuprofen and acetaminophen in children and adults: a meta-analysis and qualitative review.
Pierce CA; Voss B
Ann Pharmacother; 2010 Mar; 44(3):489-506. PubMed ID: 20150507
[TBL] [Abstract][Full Text] [Related]
15. Needle size for vaccination procedures in children and adolescents.
Beirne PV; Hennessy S; Cadogan SL; Shiely F; Fitzgerald T; MacLeod F
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010720. PubMed ID: 30091147
[TBL] [Abstract][Full Text] [Related]
16. Determinants of antipyretic misuse in children up to 5 years of age: a cross-sectional study.
Bilenko N; Tessler H; Okbe R; Press J; Gorodischer R
Clin Ther; 2006 May; 28(5):783-93. PubMed ID: 16861100
[TBL] [Abstract][Full Text] [Related]
17. A review of ibuprofen and acetaminophen use in febrile children and the occurrence of asthma-related symptoms.
Kanabar D; Dale S; Rawat M
Clin Ther; 2007 Dec; 29(12):2716-23. PubMed ID: 18201589
[TBL] [Abstract][Full Text] [Related]
18. Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus, and haemophilus B conjugate vaccine and guidance for use in infants and children.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Oct; 57(39):1079-80. PubMed ID: 18830213
[TBL] [Abstract][Full Text] [Related]
19. Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines.
Chevallier B; Vesikari T; Brzostek J; Knuf M; Bermal N; Aristegui J; Borys D; Cleerbout J; Lommel P; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S109-18. PubMed ID: 19325447
[TBL] [Abstract][Full Text] [Related]
20. Defining the key parameters for comparing reactions among acellular and whole-cell pertussis vaccines.
Pichichero ME; Christy C; Decker MD; Steinhoff MC; Edwards KM; Rennels MB; Anderson EL; Englund JA
Pediatrics; 1995 Sep; 96(3 Pt 2):588-92. PubMed ID: 7659482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
